The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer

BACKGROUND: Inflammation and metabolic syndrome (MetS) may act synergistically and possibly accelerate the initiation and progression of colorectal cancer (CRC). We prospectively examined the joint effect of MetS and inflammation on the risk of CRC. METHODS: We studied 92,770 individuals from the Ka...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tong, Fan, Yali, Zhang, Qingsong, Wang, Yiming, Yao, Nan, Song, Mengmeng, Zhang, Qi, Cao, Liying, Song, Chunhua, Shi, Hanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307555/
https://www.ncbi.nlm.nih.gov/pubmed/35715516
http://dx.doi.org/10.1007/s00011-022-01597-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307555/
https://www.ncbi.nlm.nih.gov/pubmed/35715516
http://dx.doi.org/10.1007/s00011-022-01597-9

Ejemplares similares